GRK4 and chronic obstructive pulmonary disease: Future investigations should aim to validate GRK4 expression changes at different stages of COPD and assess its clinical relevance, thereby solidifying its application as a therapeutic target and providing a scientific basis for precise treatment and intervention strategies.